Archived Press Releases |
| Date |
Title (click to view the full text) |
| 11-Aug-2008 |
Olympian Bone Health for China |
| 11-Aug-2008 |
FEATURE/Olympian Bone Health for China |
| 6-Aug-2008 |
Unigene to Release Second Quarter Financial Results and Host Conference Call |
| 10-Jul-2008 |
Unigene CEO Discusses Value of Peptides and Company's Technologies in Two Leading Pharmaceutical Trade Publications |
| 12-May-2008 |
Unigene Announces Financial Results For First Quarter 2008 |
| 12-May-2008 |
China Joint Venture Partner to Invest $2 Million in Unigene |
| 8-May-2008 |
Unigene to Release First Quarter 2008 Results and Host Conference Call |
| 29-Apr-2008 |
FDA Approves Second Improvement to Unigene's Calcitonin Manufacturing Process |
| 23-Apr-2008 |
Unigene Joint Venture Breaks Ground for Global Biotechnology Park in China |
| 17-Mar-2008 |
Unigene Announces Financial Results for Fourth Quarter and Year-End 2007 |
| 13-Mar-2008 |
Unigene Restates Policy on Analyst Reports |
| 12-Mar-2008 |
Unigene Reports Transfer of Beneficial Ownership of Shares by Management |
| 12-Mar-2008 |
Unigene Successfully Completes Phase I/II Clinical Study for Oral Calcitonin |
| 11-Mar-2008 |
Unigene to Release Year End Results and Host Conference Call on March 18, 2008 |
| 10-Mar-2008 |
Boning up on New Osteoporosis Risk Guidelines |
| 10-Mar-2008 |
FEATURE/Boning up on New Osteoporosis Risk Guidelines |
| 13-Feb-2008 |
Unigene to Present at the 20th Annual Roth Capital Partners Growth Stock Conference |
| 12-Feb-2008 |
Unigene Announces Publication of Initial Results of Site-Directed Bone Growth Studies |
| 11-Feb-2008 |
Unigene Initiates Phase I/II Clinical Study for Oral Calcitonin |
| 17-Jan-2008 |
FDA Approves Improvement to Unigene's Calcitonin Manufacturing Process |
| 8-Jan-2008 |
Unigene and Shijiazhuang Pharmaceutical Group to Expand Chinese Joint Venture |
| 19-Dec-2007 |
Unigene States That New Government Study Reports That Many Osteoporosis Medications Prevent Fractures, but None is Proven Best |
| 12-Nov-2007 |
Unigene Announces Financial Results for the Third Quarter of 2007 |
| 7-Nov-2007 |
Unigene to Release Third Quarter Results and Host Conference Call on November 12th |
| 1-Nov-2007 |
Unigene to Present at the Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference |
| 25-Oct-2007 |
Unigene Reports Successful Completion of Oral Calcitonin Human Study |
| 20-Sep-2007 |
Unigene and Yale Present Longer-Term Animal Data for Novel Site-Directed Bone Growth Technology |
| 18-Sep-2007 |
Unigene to Present at the UBS Global Life Sciences Conference |
| 29-Aug-2007 |
Unigene to Present at the ROTH 2007 New York Conference |
| 10-Aug-2007 |
Unigene In-Licenses Potential Therapies for Inflammation and Cardiovascular Disease from University of London |
| 10-Aug-2007 |
Unigene Announces Financial Results for the Second Quarter of 2007 |
| 7-Aug-2007 |
Unigene to Release Second Quarter Results and Host Conference Call on August 10th |
| 3-Aug-2007 |
Unigene to Present at Canaccord Adams' 27th Global Growth Conference |
| 2-Aug-2007 |
Unigene Initiates Oral Calcitonin Clinical Study in Humans |
| 27-Jun-2007 |
Unigene and Yale Present Novel Site-Directed Bone Growth Technology for Strengthening Bones |
| 18-Jun-2007 |
Unigene to Present Initial Animal Data on Site-Directed Bone Growth |
| 5-Jun-2007 |
Unigene Reports That Oral Calcitonin Phase III Clinical Study for Osteoarthritis Treatment is Initiated |
| 11-May-2007 |
Unigene Announces Strong Increase in Revenue and Improved Quarterly Income for First Quarter 2007 |
| 11-May-2007 |
Unigene Restructures Debt |
| 8-May-2007 |
Unigene to Release First Quarter 2007 Results and Host Conference Call on May 11th |
| 7-May-2007 |
CORRECTING and REPLACING Unigene to Present at the UBS Global Generic and Specialty Pharmaceuticals Conference on May 8, 2007 |
| 20-Mar-2007 |
Unigene's Site-Directed Bone Growth Technology May Have Multiple Large Market Applications According to New Market Analysis |
| 19-Mar-2007 |
Unigene Announces Financial Results for Fourth Quarter and Year-End 2006 |
| 13-Mar-2007 |
Unigene to Release Fourth Quarter and Year-End 2006 Results and Host Conference Call on March 19th |
| 27-Feb-2007 |
Unigene Achieves $5.5 Million Milestone in Calcitonin Collaboration for Phase III Initiation |
| 15-Feb-2007 |
Unigene Receives Phase II SBIR Grant for Novel Peptide Discovery Program |
| 29-Jan-2007 |
Unigene Enters Supply Agreement to Manufacture Osteoporosis Peptide |
| 30-Nov-2006 |
Unigene Engages University Clinicians to Advise on Bone Growth Program |
| 9-Nov-2006 |
Unigene Announces Results for the Third Quarter of 2006 |
| 8-Nov-2006 |
Unigene to Release Third Quarter 2006 Results and Host Conference Call on November 10th |
| 3-Nov-2006 |
Unigene to Present at the 8th Annual Rodman and Renshaw Healthcare Conference on November 8th 2006 |
| 19-Sep-2006 |
Unigene to Present at the UBS Global Life Sciences Conference on September 27, 2006 |
| 30-Aug-2006 |
Unigene to Present at the ThinkEquity Partners Conference; Fortical(R) Sales to Upsher-Smith Resume |
| 11-Aug-2006 |
Unigene Named Ninth Fastest Growing Technology Company in New Jersey in Deloitte's Technology Fast 50 Program |
| 10-Aug-2006 |
Unigene Announces Results for the Second Quarter of 2006 |
| 8-Aug-2006 |
Unigene to Release Second Quarter 2006 Results and Host Conference Call |
| 25-Jul-2006 |
Unigene and Upsher-Smith File Patent Infringement Lawsuit against Canadian Drug Manufacturer |
| 11-May-2006 |
Unigene Announces Results for the First Quarter of 2006 |
| 10-May-2006 |
Unigene Enters into Exclusive Distribution Agreement for Fortical(R) Nasal Spray in Israel |
| 9-May-2006 |
Unigene to Release First Quarter 2006 Results and Host Conference Call |
| 31-Mar-2006 |
Unigene Begins Media Education Initiative to Promote Bone Health; CEO Interviewed by Television Stations Nationwide about Osteoporosis |
| 17-Mar-2006 |
Unigene Announces Results for 2005 |
| 17-Mar-2006 |
Unigene Enters into Agreement to Sell $13 Million in Equity Securities |
| 14-Mar-2006 |
Unigene to Release Year-End Results and Host Conference Call |
| 15-Feb-2006 |
Unigene Elects Peter Slusser and Bruce Morra, Senior Financial and Pharmaceutical Executives, to Board of Directors |
| 22-Nov-2005 |
Unigene Reports Record Revenue and Operating Profit for Third Quarter; Net Income of $.10 Per Share for Three Months Ended September 30, 2005 |
| 17-Nov-2005 |
Unigene Schedules Third Quarter Results Conference Call |
| 2-Nov-2005 |
Unigene Laboratories to Present at the Rodman and Renshaw Techvest 7th Annual Healthcare Conference |
| 20-Oct-2005 |
Unigene Laboratories to Present at the PIPEs Conference 2005 |
| 18-Oct-2005 |
Unigene Laboratories To Present at the C.E. Unterberg, Towbin 2005 Life Sciences Conference |
| 26-Sep-2005 |
Unigene to Present at the UBS Warburg Global Life Sciences Conference |
| 19-Sep-2005 |
Unigene and Yale University Invent Technologies to Build New Bone |
| 14-Sep-2005 |
Unigene Receives $4 Million Milestone Payment for Fortical(R) Approval; Product Rollout on Target |
| 8-Sep-2005 |
Unigene to Present at the ThinkEquity Partners Conference |
| 22-Aug-2005 |
Unigene and Novartis Complete Technology Transfer For Calcitonin Manufacturing; Sandoz Successfully Concludes First Full-Scale Production Campaign |
| 16-Aug-2005 |
Upsher-Smith launches NEW Fortical(R) Nasal Spray for postmenopausal osteoporosis |
| 15-Aug-2005 |
FDA Approves Fortical, Unigene's Nasal Calcitonin Product for Postmenopausal Osteoporosis; Unigene to Receive $4 Million Milestone Payment from Upsher-Smith |
| 19-Jul-2005 |
Upsher-Smith Laboratories and Unigene Laboratories Clarify Upsher-Smith's Press Release Issued Yesterday |
| 18-Jul-2005 |
Upsher-Smith Laboratories and Unigene Laboratories Clarify Upsher-Smith's Press Release Issued Earlier Today |
| 13-Apr-2005 |
Unigene Completes $3 Million Private Placement with Fusion Capital Unigene Terminates Fusion Common Stock Purchase Agreement |
| 31-Mar-2005 |
Unigene Announces Results for 2004 |
| 11-Feb-2005 |
Unigene Appoints Marvin L. Miller, Senior Pharmaceutical Executive, to Board of Directors |
| 15-Nov-2004 |
Unigene Announces Profitable Third Quarter |
| 14-Oct-2004 |
Unigene to Present at the Rodman Renshaw Annual Healthcare Conference |
| 12-Oct-2004 |
Unigene's Oral PTH Osteoporosis Product Successfully Tested in Phase I Study |
| 23-Sep-2004 |
Unigene to Present at the UBS Warburg Global Life Sciences Conference |
| 9-Aug-2004 |
Unigene Achieves First Milestone in Calcitonin Collaboration $2 Million Milestone Payment to be Received |
| 27-Jul-2004 |
Unigene's Peptide Manufacturing Technology Featured in BioPharm International Article |
| 13-Jul-2004 |
Unigene Laboratories Appoints Robert F. Hendrickson, Former Merck Executive, to Board |
| 30-Jun-2004 |
Unigene's Oral Drug Delivery Technology Featured in BioPharm International Article |
| 22-Jun-2004 |
Unigene to Receive $4 Million from GlaxoSmithKline for Commencement of Phase I Study for Osteoporosis Product |
| 8-Apr-2004 |
Unigene Announces Licensing and Manufacturing Agreements for Calcitonin with Novartis; Unigene Eligible to Receive $18.7 Million in Addition to Royalties |
| 8-Jan-2004 |
Unigene Receives FDA Approvable Letter for Its Nasal Calcitonin Osteoporosis Product |
